These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10666677)

  • 1. Differential display reveals deteriorated mRNA levels of NADH3 (complex I) in cerebellum of patients with Down syndrome.
    Krapfenbauer K; Yoo BC; Cairns N; Lubec G
    J Neural Transm Suppl; 1999; 57():211-20. PubMed ID: 10666677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential display reveals downregulation of the phospholipid transfer protein (PLTP) at the mRNA level in brains of patients with Down syndrome.
    Krapfenbauer K; Yoo BC; Kim SH; Cairns N; Lubec G
    Life Sci; 2001 Mar; 68(18):2169-79. PubMed ID: 11324722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of DNAse I in brain of patients with Down syndrome.
    Schatzmann-Turhani D; Labudova O; Yeghiazaryan K; Rink H; Hauser E; Cairns N; Lubec G
    J Neural Transm Suppl; 1999; 57():353-62. PubMed ID: 10666689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired brain glucose metabolism in patients with Down syndrome.
    Labudova O; Cairns N; Kitzmüller E; Lubec G
    J Neural Transm Suppl; 1999; 57():247-56. PubMed ID: 10666680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of the transcription factor scleraxis in brain of patients with Down syndrome.
    Yeghiazaryan K; Turhani-Schatzmann D; Labudova O; Schuller E; Olson EN; Cairns N; Lubec G
    J Neural Transm Suppl; 1999; 57():305-14. PubMed ID: 10666685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain vasopressin levels in Down syndrome and Alzheimer's disease.
    Labudova O; Fang-Kircher S; Cairns N; Moenkemann H; Yeghiazaryan K; Lubec G
    Brain Res; 1998 Sep; 806(1):55-9. PubMed ID: 9739107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human brain nascent polypeptide-associated complex alpha subunit is decreased in patients with Alzheimer' s disease and Down syndrome.
    Kim SH; Shim KS; Lubec G
    J Investig Med; 2002 Jul; 50(4):293-301. PubMed ID: 12109594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered gene expression in fetal Down syndrome brain as revealed by the gene hunting technique of subtractive hybridization.
    Kitzmueller E; Labudova O; Rink H; Cairns N; Lubec G
    J Neural Transm Suppl; 1999; 57():99-124. PubMed ID: 10666671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning of the rat NADH:ubiquinone oxidoreductase subunit and its up-regulation in the facial muscle after denervation: detected by means of differential display.
    Kitahara T; Takeda N; Kubo T; Kiyama H
    Neurol Res; 1996 Aug; 18(4):329-36. PubMed ID: 8875451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased phosphoglycerate kinase in the brains of patients with Down's syndrome but not with Alzheimer's disease.
    Labudova O; Kitzmueller E; Rink H; Cairns N; Lubec G
    Clin Sci (Lond); 1999 Mar; 96(3):279-85. PubMed ID: 10029564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the dihydropyrimidinase related protein 2 (DRP-2) in Down syndrome and Alzheimer's disease brain is downregulated at the mRNA and dysregulated at the protein level.
    Lubec G; Nonaka M; Krapfenbauer K; Gratzer M; Cairns N; Fountoulakis M
    J Neural Transm Suppl; 1999; 57():161-77. PubMed ID: 10666674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased protein levels of complex I 30-kDa subunit in fetal Down syndrome brains.
    Kim SH; Fountoulakis M; Dierssen M; Lubec G
    J Neural Transm Suppl; 2001; (61):109-16. PubMed ID: 11771736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of several mitochondrial and nuclear genes encoding the subunits of electron transport chain enzyme complexes, cytochrome c oxidase, and NADH dehydrogenase, in different brain regions in Alzheimer's disease.
    Aksenov MY; Tucker HM; Nair P; Aksenova MV; Butterfield DA; Estus S; Markesbery WR
    Neurochem Res; 1999 Jun; 24(6):767-74. PubMed ID: 10447460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased transcription factor junD in brains of patients with Down syndrome.
    Labudova O; Krapfenbauer K; Moenkemann H; Rink H; Kitzmüller E; Cairns N; Lubec G
    Neurosci Lett; 1998 Aug; 252(3):159-62. PubMed ID: 9739985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cell-cycle negative regulatory gene ANA is over-expressed in the brain tissues of patients with Down syndrome].
    He XJ; Zhang Q; Ma LP; Yang LJ; Shen H; Guo JZ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 37(6):608-11. PubMed ID: 16378112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The reduction of NADH ubiquinone oxidoreductase 24- and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer's disease.
    Kim SH; Vlkolinsky R; Cairns N; Fountoulakis M; Lubec G
    Life Sci; 2001 May; 68(24):2741-50. PubMed ID: 11400916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nuclear-encoded human NADH:ubiquinone oxidoreductase NDUFA8 subunit: cDNA cloning, chromosomal localization, tissue distribution, and mutation detection in complex-I-deficient patients.
    Triepels R; van den Heuvel L; Loeffen J; Smeets R; Trijbels F; Smeitink J
    Hum Genet; 1998 Nov; 103(5):557-63. PubMed ID: 9860297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine-specific protein C, a marker of neuronal differentiation, is reduced in brain of patients with Down syndrome and Alzheimer's disease.
    Kim SH; Yoo BC; Broers JL; Cairns N; Lubec G
    Biochem Biophys Res Commun; 2000 Sep; 276(1):329-34. PubMed ID: 11006125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-fos expression in brains of patients with Down syndrome.
    Greber-Platzer S; Balcz B; Cairns N; Lubec G
    J Neural Transm Suppl; 1999; 57():75-85. PubMed ID: 10666669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced aldehyde dehydrogenase levels in the brain of patients with Down syndrome.
    Lubec G; Labudova O; Cairns N; Berndt P; Langen H; Fountoulakis M
    J Neural Transm Suppl; 1999; 57():21-40. PubMed ID: 10666666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.